Diagnostic Medical Systems Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Diagnostic Medical Systems.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 13.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Potential Upside For Diagnostic Medical Systems S.A. (EPA:ALDMS) Not Without Risk
Apr 20Does Diagnostic Medical Systems (EPA:ALDMS) Have A Healthy Balance Sheet?
Dec 08Diagnostic Medical Systems S.A. (EPA:ALDMS) Stock Catapults 32% Though Its Price And Business Still Lag The Industry
Jun 09Is Diagnostic Medical Systems (EPA:ALDMS) Weighed On By Its Debt Load?
Oct 28Is Diagnostic Medical Systems (EPA:ALDMS) Using Debt In A Risky Way?
Jun 17Diagnostic Medical Systems (EPA:DGM) Has Debt But No Earnings; Should You Worry?
Nov 18Does Diagnostic Medical Systems (EPA:DGM) Have A Healthy Balance Sheet?
Jun 04What Can We Make Of Diagnostic Medical Systems' (EPA:DGM) CEO Compensation?
Dec 22In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Diagnostic Medical Systems has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 42 | -10 | N/A | N/A | N/A |
6/30/2023 | 40 | 2 | 1 | 2 | N/A |
3/31/2023 | 38 | -1 | 0 | 2 | N/A |
12/31/2022 | 37 | -5 | -2 | 1 | N/A |
6/30/2022 | 38 | -4 | -8 | -3 | N/A |
3/31/2022 | 38 | -3 | -7 | -2 | N/A |
12/31/2021 | 38 | -2 | -7 | -1 | N/A |
6/30/2021 | 37 | -3 | -8 | -4 | N/A |
3/31/2021 | 36 | -3 | -8 | -4 | N/A |
12/31/2020 | 35 | -4 | -7 | -4 | N/A |
9/30/2020 | 36 | -7 | -6 | -3 | N/A |
6/30/2020 | 36 | -3 | -5 | -2 | N/A |
3/31/2020 | 35 | -3 | -4 | -1 | N/A |
12/31/2019 | 34 | -3 | -3 | 0 | N/A |
9/30/2019 | 32 | -4 | -3 | 1 | N/A |
6/30/2019 | 31 | -5 | -3 | 1 | N/A |
3/31/2019 | 29 | -5 | -3 | 0 | N/A |
12/31/2018 | 28 | -5 | -4 | -1 | N/A |
9/30/2018 | 28 | -5 | -5 | -2 | N/A |
6/30/2018 | 29 | -5 | -6 | -3 | N/A |
3/31/2018 | 30 | -4 | -7 | -3 | N/A |
12/31/2017 | 30 | -3 | -7 | -4 | N/A |
9/30/2017 | 34 | -2 | N/A | -3 | N/A |
6/30/2017 | 37 | 0 | N/A | -2 | N/A |
3/31/2017 | 39 | -1 | N/A | -1 | N/A |
12/31/2016 | 41 | -1 | N/A | -1 | N/A |
9/30/2016 | 42 | -1 | N/A | -2 | N/A |
6/30/2016 | 42 | -1 | N/A | -3 | N/A |
3/31/2016 | 40 | -1 | N/A | -3 | N/A |
12/31/2015 | 39 | -1 | N/A | -4 | N/A |
9/30/2015 | 35 | -1 | N/A | -4 | N/A |
6/30/2015 | 32 | -1 | N/A | -3 | N/A |
3/31/2015 | 29 | -1 | N/A | -3 | N/A |
12/31/2014 | 26 | -1 | N/A | -2 | N/A |
9/30/2014 | 25 | -1 | N/A | -1 | N/A |
6/30/2014 | 24 | -1 | N/A | 0 | N/A |
3/31/2014 | 23 | -1 | N/A | 0 | N/A |
12/31/2013 | 23 | -1 | N/A | 0 | N/A |
9/30/2013 | 24 | -1 | N/A | 0 | N/A |
6/30/2013 | 26 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ALDMS's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if ALDMS's earnings are forecast to grow faster than the French market
High Growth Earnings: Insufficient data to determine if ALDMS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ALDMS's revenue is forecast to grow faster than the French market.
High Growth Revenue: Insufficient data to determine if ALDMS's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALDMS's Return on Equity is forecast to be high in 3 years time